This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Barcelona: A Roman Village Becoming a Smart City (Abridged)
Carrasco, Carlos; Ricart, Joan Enric; Berrone, PascualCase SM-1646-EInformation Technologies, Innovation and Change, StrategyOn July 2, 2014, Josep Ramon Ferrer, director of the ICT and smart city strategy at Barcelona City Council, finished the second round of meetings with the companies selected to participate in the competitive dialogue to create City OS, Barcelona's operating system. City OS was one of the key milestones in Barcelona's smart city strategy. It aimed to enable the council to acquire and process data from urban operations in a rapid, efficient, effect...Starting at €8.20
-
U.S. Universities and Technology Transfer
Hamermesh, Richard G.; Lerner, Josh; Andrews, PhillipCase HBS-812016-EEntrepreneurshipTechnology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology tra...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Syndexa and Technology Transfer at Harvard University
Hamermesh, Richard G.; Kiron, DavidCase HBS-808073-EGokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the head of Harvard's Office of Technology Development (OTD) is eager to improve Harvard's record in commercializing science. Describes the negotiations between Hotamisligil, OTD, the ne...Starting at €8.20
-
Electronic Testing Operations (Spanish version)
Cooper, Robin; Turney, Peter B.B.; Ittner, Christopher D.Case HBS-106S03Accounting and ControlExplores the obsolescence of a cost system when technology changes. In particular, it asks students to increase the number of cost center and allocation bases. The firm moves from a one-center, direct labor-hour system to a three-center, direct labor-hour and machine-hour systems.Starting at €8.20
-
Olympus Optical Company, Ltd. (A): Gestión de costes para productos de corto ciclo de vida
Cooper, RobinCase HBS-106S12Accounting and ControlOlympus Optical explora la respuesta estratégica a grandes pérdidas en su negocio de cámaras. Clave para la recuperación de Olympus fueron su extenso proceso de planificación de producto, un programa de mejora de la calidad, y un agresivo programa de reducción de costos. En particular, el caso Detalles del sistema de costeo objetivo de Olympus, que permitió a la empresa para diseñar productos de alta calidad a bajo costo.Starting at €8.20
-
Lyric Dinner Theater (B) (Spanish version)
Hamermesh, Richard G.; Sharpe, James M.Case HBS-815S17EntrepreneurshipSuplementos el caso (A). Rivka Belzer refleja en los resultados y las medidas adoptadas durante los 12 meses siguientes a su primer 6 meses en el trabajo. Suplementos el caso (A). Rivka Belzer tomó un trabajo en su empresa familiar y trabajó diligentemente durante los primeros 6 meses para convertir el negocio alrededor. Este caso suplementario esboza una serie de decisiones que hizo después de los 6 meses y reporta los resultados financieros un ...Starting at €5.74
-
Sugar Bowl (Spanish version)
Hamermesh, Richard G.; Zalosh, AlisaCase HBS-917S11StrategyShelby Givens, a recent business school graduate, returned home to Raleigh, North Carolina to help rescue her family's ailing and outdated bowling alley, Westlake Lanes. Although she cut costs and addressed inefficiencies, moving the business from near-bankruptcy to profitability in nine months, market conditions threatened the long-term viability of the business. Givens then sold her family on a new, more youth-oriented concept, an urban lounge ...Starting at €8.20
-
Note on Managing the Growing Venture (Spanish version)
Hamermesh, Richard G.; Heskett, James L.; Roberts, Michael J.Case HBS-808S03EntrepreneurshipFocuses on the strategic and organizational challenges that confront growing enterprises and the entrepreneurs who lead them. Provides an overview of how a new venture needs to change as it passes from the initial start-up to the growth phase. Explores how a venture's leadership, strategy, and execution need to evolve to deal with rapid growth. A rewritten version of an earlier note.Starting at €8.20
-
Meli Marine (Spanish version)
Hamermesh, Richard G.; Yong, SunruCase HBS-414S03StrategyMeli Marina, una empresa de transporte de contenedores, se enfrenta a una decisión estratégica importante después de una oportunidad de adquisición en sí misma ofrece interesantes. Fundada en 1974 por la familia Chang, la empresa con sede en Singapur ha hecho un hueco en el mercado del transporte intra-Asia. Después de años de éxito, la erosión de las condiciones de negocio causaron una crisis financiera y un nuevo CEO, David Tian, se trajeron....Starting at €8.20